Literature DB >> 9715846

Molecular epidemiology of HIV-1 in Brazil: high prevalence of HIV-1 subtype B and identification of an HIV-1 subtype D infection in the city of Rio de Janeiro, Brazil. Evandro Chagas Hospital AIDS Clinical Research Group.

M G Morgado1, M L Guimarães, C B Gripp, C I Costa, I Neves, V G Veloso, M I Linhares-Carvalho, L R Castello-Branco, F I Bastos, C Kuiken, E A Castilho, B Galvão-Castro, V Bongertz.   

Abstract

HIV-1-positive individuals were recruited from January 1993 to December 1996 from several cohorts receiving follow-up in the city of Rio de Janeiro, Brazil, to evaluate HIV-1 genetic variability and the potential association with modes of transmission. HIV-1 subtyping was carried out using the heteroduplex mobility assay (HMA), and those samples corresponding to the typical Brazilian subtype B variant were further identified based on the Fok I restriction fragment length polymorphism (RFLP). DNA sequencing was performed to evaluate one case of subtype D infection. From the 131 HIV-1-positive individuals analyzed, 106 (80.9%) could be identified as infected by subtype B and 20 (15.3%) by subtype F. One of the samples (0.8%) was classified as subtype D. DNA samples from 4 patients (3.0%) did not yield polymerase chain reaction (PCR)-amplified products to be typed. Based on the Fok I RFLP, 39 of the 106 subtype B samples (37%) were identified as corresponding to the typical Brazilian subtype B variant containing the GWGR motif at the tip of the V3 loop. No statistically significant association could be detected between HIV-I subtypes and modes of transmission, exposure categories, or gender. This is the first reported case of HIV-1 subtype D infection in Brazil.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9715846     DOI: 10.1097/00042560-199808150-00011

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  6 in total

1.  Development and evaluation of a DNA enzyme immunoassay method for env genotyping of subtypes A through G of human immunodeficiency virus type 1 group M, with discrimination of the circulating recombinant forms CRF01_AE and CRF02_AG.

Authors:  Jean-Christophe Plantier; Laurence Vergne; Florence Damond; Souleymane MBoup; Eitel MPoudi-NGole; Laurence Buzelay; Isabelle Farfara; Denys Brand; Martine Peeters; Françoise Brun-Vézinet; Eric Delaporte; Francis Barin
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

2.  Diagnostic detection of human immunodeficiency virus type 1 antibodies in urine: a brazilian study.

Authors:  Walter M R Oelemann; Catherine M Lowndes; Giovani C Veríssimo Da Costa; Mariza G Morgado; Luiz Roberto R Castello-Branco; Beatriz Grinsztejn; Michel Alary; Francisco I Bastos
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

3.  Genetic Characterization of HIV-1 Subtype D Near-Full-Length Proviral Genomes by Illumina Massively Parallel Sequencing Technology.

Authors:  Rodrigo Pessôa; Maria Esther Lopes; Sabri S Sanabani
Journal:  Genome Announc       Date:  2014-06-12

4.  Close phylogenetic relationship between Angolan and Romanian HIV-1 subtype F1 isolates.

Authors:  Monick L Guimarães; Ana Carolina P Vicente; Koko Otsuki; Rosa Ferreira F C da Silva; Moises Francisco; Filomena Gomes da Silva; Ducelina Serrano; Mariza G Morgado; Gonzalo Bello
Journal:  Retrovirology       Date:  2009-04-22       Impact factor: 4.602

5.  Tracing the origin and northward dissemination dynamics of HIV-1 subtype C in Brazil.

Authors:  Edson Delatorre; José C Couto-Fernandez; Monick Lindenmayer Guimarães; Ludimila Paula Vaz Cardoso; Keila Correia de Alcantara; Mariane Martins de Araújo Stefani; Hector Romero; Caio C M Freire; Atila Iamarino; Paolo M de A Zanotto; Mariza G Morgado; Gonzalo Bello
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

6.  Cross-Neutralizing Antibodies in HIV-1 Individuals Infected by Subtypes B, F1, C or the B/Bbr Variant in Relation to the Genetics and Biochemical Characteristics of the env Gene.

Authors:  Dalziza Victalina de Almeida; Karine Venegas Macieira; Beatriz Gilda Jegerhorn Grinsztejn; Valdiléa Gonçalves Veloso Dos Santos; Monick Lindenmeyer Guimarães
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.